{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:42:13Z","timestamp":1784713333764,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T00:00:00Z","timestamp":1446854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T00:00:00Z","timestamp":1446854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS003037"],"award-info":[{"award-number":["NS003037"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12031-015-0674-7","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T07:34:29Z","timestamp":1446881669000},"page":"317-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Spinal and Bulbar Muscular Atrophy Overview"],"prefix":"10.1007","volume":"58","author":[{"given":"Kenneth H.","family":"Fischbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,7]]},"reference":[{"key":"674_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ana.21540","volume":"65","author":"H Banno","year":"2009","unstructured":"Banno H, Katsuno M, Suzuki K et al (2009) Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 65:140\u2013150","journal-title":"Ann Neurol"},{"key":"674_CR2","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","volume":"24","author":"ES Chevalier-Larsen","year":"2004","unstructured":"Chevalier-Larsen ES, O\u2019Brien CJ, Wang H et al (2004) Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 24:4778\u20134786","journal-title":"J Neurosci"},{"key":"674_CR3","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/hmg\/ddt527","volume":"23","author":"JP Chua","year":"2014","unstructured":"Chua JP, Reddy SL, Merry DE et al (2014) Transcriptional activation of TFEB\/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum Mol Genet 23:1376\u20131386","journal-title":"Hum Mol Genet"},{"key":"674_CR4","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nn.3787","volume":"17","author":"CJ Cortes","year":"2014","unstructured":"Cortes CJ, Miranda HC, Frankowski H et al (2014a) Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat Neurosci 17:1180\u20131189","journal-title":"Nat Neurosci"},{"key":"674_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","volume":"82","author":"CJ Cortes","year":"2014","unstructured":"Cortes CJ, Ling SC, Guo LT et al (2014b) Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82:295\u2013307","journal-title":"Neuron"},{"key":"674_CR6","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1523\/JNEUROSCI.3021-12.2013","volume":"33","author":"H Doi","year":"2013","unstructured":"Doi H, Adachi H, Katsuno M et al (2013) p62\/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model. J Neurosci 33:7710\u20137727","journal-title":"J Neurosci"},{"key":"674_CR7","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Rhodes LE, Kokkinis AD et al (2011) Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.\u00a0 Lancet Neurol. 10:140\u2013147","DOI":"10.1016\/S1474-4422(10)70321-5"},{"key":"674_CR8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/mus.23814","volume":"47","author":"KH Fischbeck","year":"2013","unstructured":"Fischbeck KH (2013) A role for androgen reduction treatment in Kennedy disease? Muscle Nerve 47:789","journal-title":"Muscle Nerve"},{"key":"674_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2014.05.038","volume":"70","author":"C Grunseich","year":"2014","unstructured":"Grunseich C, Zukosky K, Kats IR et al (2014a) Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients. Neurobiol Dis 70:12\u201320","journal-title":"Neurobiol Dis"},{"key":"674_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.nmd.2014.06.441","volume":"24","author":"C Grunseich","year":"2014","unstructured":"Grunseich C, Kats IR, Bott LC et al (2014b) Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat. Neuromuscul Disord 24:978\u2013981","journal-title":"Neuromuscul Disord"},{"key":"674_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/hmg\/ddu445","volume":"24","author":"M Iida","year":"2015","unstructured":"Iida M, Katsuno M, Nakatsuji H et al (2015) Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors. Hum Mol Genet 24:314\u2013329","journal-title":"Hum Mol Genet"},{"key":"674_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno M, Adachi H, Doyu M et al (2003) Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9:768\u2013773","journal-title":"Nat Med"},{"key":"674_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno M, Banno H, Suzuki K et al (2010) Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:875\u2013884","journal-title":"Lancet Neurol"},{"key":"674_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"A La Spada","year":"1991","unstructured":"La Spada A, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77\u201379","journal-title":"Nature"},{"key":"674_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","volume":"7","author":"AP Lieberman","year":"2014","unstructured":"Lieberman AP, Yu Z, Murray S et al (2014) Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep 7:774\u2013784","journal-title":"Cell Rep"},{"key":"674_CR16","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/nm.2932","volume":"18","author":"M Minamiyama","year":"2012","unstructured":"Minamiyama M, Katsuno M, Adachi H et al (2012) Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. Nat Med 18:1531\u20131538","journal-title":"Nat Med"},{"key":"674_CR17","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/nm.2791","volume":"18","author":"Y Miyazaki","year":"2012","unstructured":"Miyazaki Y, Adachi H, Katsuno M et al (2012) Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat Med 18:1136\u20131141","journal-title":"Nat Med"},{"key":"674_CR18","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/hmg\/ddm109","volume":"16","author":"I Palazzolo","year":"2007","unstructured":"Palazzolo I, Burnett BG, Young JE et al (2007) Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet 16:1593\u20131603","journal-title":"Hum Mol Genet"},{"key":"674_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","volume":"63","author":"I Palazzolo","year":"2009","unstructured":"Palazzolo I, Stack C, Kong L et al (2009) Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63:316\u2013328","journal-title":"Neuron"},{"key":"674_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nature05853","volume":"447","author":"UB Pandey","year":"2007","unstructured":"Pandey UB, Nie Z, Batlevi Y et al (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447:859\u2013863","journal-title":"Nature"},{"key":"674_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2119\/molmed.2012.00271","volume":"18","author":"C Rinaldi","year":"2012","unstructured":"Rinaldi C, Bott LC, Chen KL et al (2012) Insulin-like growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol Med 18:1261\u20131268","journal-title":"Mol Med"},{"key":"674_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuron.2014.04.005","volume":"82","author":"C Rinaldi","year":"2014","unstructured":"Rinaldi C, Bott LC, Fischbeck KH (2014) Muscle matters in Kennedy\u2019s disease. Neuron 82:251\u2013253","journal-title":"Neuron"},{"issue":"21","key":"674_CR23","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1093\/hmg\/ddv300","volume":"24","author":"K Sahashi","year":"2015","unstructured":"Sahashi K, Katsuno M, Hung G et al (2015) Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 24(21):5985\u20135994","journal-title":"Hum Mol Genet"},{"key":"674_CR24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/acn3.208","volume":"2","author":"JA Shrader","year":"2015","unstructured":"Shrader JA, Kats I, Kokkinis A et al (2015) A randomized controlled trial of functional exercise in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol 2:739\u2013747","journal-title":"Ann Clin Transl Neurol"},{"key":"674_CR25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/hmg\/ddn419","volume":"18","author":"K Tokui","year":"2009","unstructured":"Tokui K, Adachi H, Waza M et al (2009) 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum Mol Genet 18:898\u2013910","journal-title":"Hum Mol Genet"},{"key":"674_CR26","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm1298","volume":"1","author":"M Waza","year":"2005","unstructured":"Waza M, Adachi H, Katsuno M et al (2005) 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med 1:1088\u20131095","journal-title":"Nat Med"},{"key":"674_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nm1547","volume":"13","author":"Z Yang","year":"2007","unstructured":"Yang Z, Chang YJ, Yu IC et al (2007) ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat Med 13:348\u2013353","journal-title":"Nat Med"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-015-0674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-015-0674-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-015-0674-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-015-0674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:55:07Z","timestamp":1589738107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-015-0674-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["674"],"URL":"https:\/\/doi.org\/10.1007\/s12031-015-0674-7","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,7]]},"assertion":[{"value":"2 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}